17.05.2010 • News

Hexion Specialty Chemicals Posts Q1 Loss

Privately held Hexion Specialty Chemicals posted a first-quarter loss, though revenue and demand for its products jumped.

The company reported a net loss of $7 million compared with net income of $117 million for the same period last year, which included a large gain from early debt repayment. Revenue rose 28 percent to $1.17 billion, while volume rose 25%.

"We remain optimistic that the gradual recovery in volumes will continue in 2010," Chief Executive Craig O. Morrison said. "However, we believe the extent of the economic recovery is likely to vary significantly by industry sector and geographical region."

Hexion is owned by Apollo Management LP, a private equity firm that also owns the Harrah's casino chain and Norwegian Cruise Lines.

Company

Hexion Specialty Chemicals

Gennaerstr. 2-4
58642 Iserlohn
Germany

Company contact







Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read